Join Us for the 2024 Colorado Privacy Summit on September 26th!

Asia Market Expertise

An aerial view of a busy city with busy roads at night.

ASIA Expertise

Your Partner for Navigating Complex and Dynamic Asian Markets

With deep insights into Asia’s local regulations, stakeholder practices, and evolving trends, we empower healthcare clients to make critical decisions through our strong in-country presence.

Deep Expertise Across Asia 

With regional headquarters in Beijing and Shanghai, and a full-time team of 40+ experts, we offer a strong local presence and infrastructure to support clients throughout Asia.

East Asia

  • Greater China
  • Japan
  • South Korea

South Asia & Oceania

  • India
  • Australia

Southeast Asia

  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Philippines
  • Vietnam
Oceania map showing the deep expertise of SAI MedPartners' Asia team across Asia.

We Understand the Unique Challenges in Asia and Offer a Comprehensive Suite of Strategic Solutions

Challenges in Asia

Competitive Intelligence

  • Unique competitive pattern in Asia vs. US and EU
  • Fast growing Asian innovative assets impact both local and global markets

Market Access

  • Diversified market access challenges & stakeholders
  • Complex local pricing and reimbursement consideration and challenges

Market Research

  • Country specific EPI  pattern and care pathway
  • Unique local clinical behavior, adoption rationales, and unmet needs

Policy Impact

  • Asian country specific regulation and trends
  • Impactful policies reshape the market, e.g. VBP and NRDL evolution in China

BD Assessment

  • Asia BD opportunity for local & global commercialization
  • The success of deal sourcing and execution requires solid local knowledge of Asia

SAI Med Asia Solutions

  • Competitive landscaping and monitoring
  • Best practice and industry mitigation strategies
  • Analog and benchmarking
  • Lifecycle price and revenue strategy and access roadmap
  • Key stakeholder mapping and engagements
  • Value demonstration and communications
  • Market strategy and opportunities forecasting
  • Customer behavior analysis and insights
  • Omni-channel touchpoints and engagements
  • Policy sharing and navigation
  • Key stakeholder panel discussion
  • Policy strategy and transformation
  • Advocacy and policy shaping
  • BD opportunity assessment
  • Early assets evaluation
  • Targeting sourcing and screening
  • Outsourcing and deal support
  • Local partnerships

Challenges in Asia

SAI Med Asia Solutions

Competitive Intelligence

Challenges in Asia

  • Unique competitive pattern in Asia vs. US and EU
  • Fast growing Asian innovative assets impact both local and global markets

SAI Med Asia Solutions

  • Competitive landscaping and monitoring
  • Best practice and industry mitigation strategies
  • Analog and benchmarking

Market Access

Challenges in Asia

  • Diversified market access challenges & stakeholders
  • Complex local pricing and reimbursement consideration and challenges

SAI Med Asia Solutions

  • Lifecycle price and revenue strategy and access roadmap
  • Key stakeholder mapping and engagements
  • Value demonstration and communications

Market Research

Challenges in Asia

  • Country specific EPI  pattern and care pathway
  • Unique local clinical behavior, adoption rationales, and unmet needs

SAI Med Asia Solutions

  • Market strategy and opportunities forecasting
  • Customer behavior analysis and insights
  • Omni-channel touchpoints and engagements

Policy Impact

Challenges in Asia

  • Asian country specific regulation and trends
  • Impactful policies reshape the market, e.g. VBP and NRDL evolution in China

SAI Med Asia Solutions

  • Policy sharing and navigation
  • Key stakeholder panel discussion
  • Policy strategy and transformation
  • Advocacy and policy shaping

BD Assessment

Challenges in Asia

  • Asia BD opportunity for local & global commercialization
  • The success of deal sourcing and execution requires solid local knowledge of Asia

SAI Med Asia Solutions

  • BD opportunity assessment
  • Early assets evaluation
  • Targeting sourcing and screening
  • Outsourcing and deal support
  • Local partnerships

We Engage with Regional Stakeholders Across
the Healthcare Landscape

Medical

  • PIs, KOLs, and a Broad Range of Physicians
  • Hospital Management
  • Pharmacists
  • Nurses
  • Medical Associations

Authority

  • Policy Makers and Influencers
  • Registration Authorities
  • National and Regional Payers
  • HTA Experts

Industry

  • Pharmaceutical and Bio-tech Players
  • Med-tech and IVD Players
  • Channel Players: CSOs, Distributors, Retails, etc.
  • Service Players: CRO, CDMO/CMO, etc.
  • Digital Players: Digital Solution Providers, AI Players, etc.

Patient

  • Patients and Caregivers
  • Patient Groups
  • Patient Related Charity Foundations

Our Strategic Alliances Allow us to Generate Insights
Beyond Traditional Stakeholders

Partnerships with authorities and industry players provide us access to the voices that shape healthcare policy

Policy Interpretation & Industry Execution Assessment

  • Partner with China Policy Center
  • Advocated by policy think tank
  • Address industry players’ hot topics
  • Led to a series of panel discussions to explore executional optimization solutions

BeSD Localization to Support China NIP Strategy​

  • Partner with China CDC and the China Association of Vaccine
  • BeSD localization design and execution support
  • Optimize national vaccine strategy with evidence support
  • Whitepaper and publications
Scroll to Top